A Multicenter Phase II Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy

被引：0
|
作者：
Kim, Hae Su [1 ]
Lim, Tae Kyu [1 ]
Nam, Seung-Hyun [1 ]
Choi, Yoon Hee [2 ]
Won, Young-Woong [3 ]
Kim, Hoon-Gu [4 ]
Sun, Jong-Mu [5 ]
Kwon, Jung Hye [6 ]
Kim, Ki-Hyang [7 ]
Jang, Joung Soon [8 ]
Kang, Jin Hyoung [9 ]
Kim, Bong-Seog [1 ]
机构：
[1] Vet Hlth Serv Med Ctr, Div Hematol Oncol, Dept Med, Seoul, South Korea
[2] Dongnam Inst Radiol & Med Sci, Div Hematol Oncol, Dept Med, Busan, South Korea
[3] Hanyang Univ, Guri Hosp, Guri, South Korea
[4] Gyeongsang Natl Univ, Jinju, South Korea
[5] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
[6] Hallym Univ, Med Ctr, Seoul, South Korea
[7] INJE Univ, Busan Paik Hosp, Busan, South Korea
[8] Chung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[9] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Prospective study; NSCLC; gefitinib;
D O I：
10.1016/j.jtho.2016.11.1739
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-072
引用
收藏
页码：S1233 / S1234
页数：2
相关论文
共 50 条
  • [1] A Phase II Trial of Pictilisib with Chemotherapy in First-Line Squamous NSCLC
    Spigel, David
    Luft, Alexander
    Vynnychenko, Ihor
    Fadeeva, Natalia
    Mark, Zsuzsanna
    Ponce, Santiago
    Matrosova, Marina
    Goldschmidt, Jerome
    Szima, Barna
    Saleh, Mansoor
    Lackner, Mark
    Gendreau, Steve
    Bassett, Katia
    Spoerke, Jill
    Koeppen, Hartmut
    Gilbert, Houston
    Jin, Huan
    Shankar, Geetha
    Lin, Wei
    Denis, Fabrice
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S375 - S375
  • [2] Gefitinib Superior to Doublet Chemotherapy in Phase III Asian First-Line Advanced NSCLC Study
    不详
    [J]. ONCOLOGY-NEW YORK, 2008, 22 (11): : 1246 - 1246
  • [3] Phase II study of cetuximab in combination with modified FOLFIRI in patients with advanced gastric cancer who failed first-line chemotherapy (EFFI study)
    Li, J.
    Liu, X.
    Wang, B. Y.
    Guo, W. J.
    Lin, J. L.
    Zhu, X. D.
    Zhang, J.
    Liu, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Efficacy of Chemotherapy after First-Line Gefitinib for EGFR-Mutant NSCLC Patients
    Kuwako, Tomohito
    Imai, Hisao
    Masuda, Tomomi
    Miura, Yosuke
    Yoshino, Reiko
    Kaira, Kyoichi
    Shimizu, Kimihiro
    Sunaga, Noriaki
    Tomizawa, Yoshio
    Ishihara, Shinichi
    Mogi, Akira
    Hisada, Takeshi
    Minato, Koichi
    Takise, Atsushi
    Saito, Ryusei
    Yamada, Masanobu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S646 - S646
  • [5] GEFITINIB/CHEMOTHERAPY VERSUS CHEMOTHERAPY IN EGFR MUTATION-POSITIVE NSCLC AFTER PROGRESSION ON FIRST-LINE GEFITINIB: IMPRESS STUDY DESIGN
    Wu, Y. -L.
    Mok, T.
    Soria, J. -C.
    Nakagawa, K.
    Zhang, X.
    Miao, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 23 - 23
  • [6] ORCHARD: A Phase II Platform Study in Patients with Advanced NSCLC Who Have Progressed on First-Line Osimertinib Therapy
    Yu, H.
    Goldberg, S.
    Le, X.
    Piotrowska, Z.
    Smith, P.
    Mensi, I.
    Kirova, B.
    Chmielecki, J.
    Li-Sucholeicki, X.
    Szekeres, P.
    Doughton, G.
    Patel, G.
    Jewsbury, P.
    Riess, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S647 - S647
  • [7] Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC
    Andric, Zoran
    Galffy, Gabriella
    Dols, Manuel Cobo
    Szima, Barna
    Stojanovic, Goran
    Petrovic, Marina
    Felip, Enriqueta
    Baz, David Vicente
    Aix, Santiago Ponce
    Juan-Vidal, Oscar
    Szalai, Zsuzsanna
    Losonczy, Gyorgy
    Blanco, Antonio Calles
    Bernabe, Reyes
    Ledo, Gema Garcia
    Hernandez, Andres Aguilar
    Duecker, Klaus
    Zhou, Dongli
    Schroeder, Andreas
    Guezel, Guelseren
    Ciardiello, Fortunato
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (02):
  • [8] A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer
    Gelibter, Alain J.
    Gamucci, Teresa
    Pollera, Camillo F.
    Di Costanzo, Francesco
    Nuzzo, Carmen
    Gabriele, Angela
    Signorelli, Carlo
    Gasperoni, Silvia
    Ferraresi, Virginia
    Giannarelli, Diana
    Cognetti, Francesco
    Zeuli, Massimo
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (09) : 2117 - 2123
  • [9] First-line single agent treatment with gefitinib in patients with advanced NSCLC
    Brossart, Peter
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (08) : 490 - 491
  • [10] A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma
    Lee, Jeeyun
    Im, Young-Hyuck
    Cho, Eun Yoon
    Hong, Yong Sang
    Lee, Hyo Rak
    Kim, Hyo Song
    Kim, Mi-Jin
    Kim, Kwhanmien
    Kang, Won Ki
    Park, Keunchil
    Shim, Young Mog
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 77 - 84
12345